RATTANINDIA ENT Latest Share Price (RTNINDIA)
TODAY IN ONE LINE
RTNINDIA is little changed at ₹27.68 on average volume — a quiet consolidation day.
With a market cap of ₹3,834.42 Cr., it trades at a P/E of N/A. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
RATTANINDIA ENT flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 74.9% skin-in-the-game
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Sales ContractionQuarterly sales dropped 99.7% YoY
Latest RATTANINDIA ENT News
What changed recently?
Recent events, corporate actions, and announcements.
RATTANINDIA ENT valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for RATTANINDIA ENT, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
RATTANINDIA ENT technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for RATTANINDIA ENT — derived from the latest tape, not yesterday's close.
RATTANINDIA ENT last traded at ₹27.68 with an intraday range of ₹27–₹28 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹27.68| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 30.12 | +2.44 | +8.82% |
| R3 | 29.12 | +1.44 | +5.20% |
| R2 | 28.56 | +0.88 | +3.18% |
| R1 | 28.12 | +0.44 | +1.59% |
| PIVOT | 27.56 | -0.12 | -0.43% |
| CURRENT | 27.68 | — | — |
| S1 | 27.12 | -0.56 | -2.02% |
| S2 | 26.56 | -1.12 | -4.05% |
| S3 | 26.12 | -1.56 | -5.64% |
| S4 | 25.12 | -2.56 | -9.25% |
RTNINDIA is trading Above CPR, indicating Bullishness
CPR is Average
Day's range: ₹27–₹27.48
Trading Inside opening range
RATTANINDIA ENT financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for RATTANINDIA ENT — consolidated or standalone — with margins, YoY growth and key ratios inline.
RATTANINDIA ENT reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹3,834.42 Cr. and reported EPS of ₹-0.06.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Interest Earned | 8 | 8 ▼ 5.9% |
| 10 | 6 ▼ 33.7% | |
| Total Income | 6,876 | 7,537 ▲ 9.6% |
| Net Interest Income (NII)Derived | 8 | 8 ▼ 5.9% |
| Profit Before Tax (PBT) | 152 | -163 ▼ 207.1% |
| 71 | 4 ▼ 94.8% | |
| Effective Tax %Derived | 46.87% | -2.28% |
| Total Profit for Period | 81 | -166 ▼ 306.1% |
| Less: Non-controlling Interests | -4 | -1 ▲ 75.1% |
| Net Profit (Owner's PAT)Derived | 84 | -165 ▼ 295.9% |
| PAT Growth YoY %Derived | -80.19% | -295.91% |
| Earnings Per Share (EPS ₹) | 0.61 | -1.20 ▼ 296.7% |
| Diluted Shares Outstanding (Cr) | 138 | 138 ▲ 0.0% |
| Share of Profit from Associates/JVs | — | — |
| Other Comprehensive Income (Net of Tax) | 1 | 3 ▲ 341.2% |
| Fees & Commission Expense | 920 | 1,309 ▲ 42.3% |
| Impairment On Financial Instruments | 1 | 0 ▼ 88.9% |
| Net Gain Fair Value Changes | 166 | 2 ▼ 99.0% |
| Net Loss Fair Value Changes | — | 172 |
| Revenue Sale Of Product | 6,687 | 7,517 ▲ 12.4% |
| Rental Income | 0 | — ▼ 100.0% |
| Period | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|
| Interest Earned | — | — | — | — | — | 8 | 8 ▼ 5.9% | |
2 | 2 ▲ 9.9% | 579 ▲ 33558.6% | 14 ▼ 97.5% | 582 ▲ 3936.2% | 10 ▼ 98.3% | 6 ▼ 33.7% | ||
| Total Income | 2 | 2 ▲ 16.2% | 593 ▲ 32478.2% | 4,138 ▲ 597.9% | 6,192 ▲ 49.6% | 6,876 ▲ 11.1% | 7,537 ▲ 9.6% | |
| Net Interest Income (NII)Derived | — | — | — | — | — | 8 | 8 ▼ 5.9% | |
| Profit Before Tax (PBT) | -0 | 0 ▲ 101.8% | 554 ▲ 7915137.1% | -261 ▼ 147.0% | 453 ▲ 273.6% | 152 ▼ 66.4% | -163 ▼ 207.1% | |
— | — | 0 | 13 ▲ 6174.0% | 28 ▲ 119.9% | 71 ▲ 153.8% | 4 ▼ 94.8% | ||
| Effective Tax %Derived | — | — | 0.04% | -4.89% | 6.20% | 46.87% | -2.28% | |
| Total Profit for Period | -153 | 0 ▲ 100.0% | 554 ▲ 7912232.9% | -286 ▼ 151.7% | 424 ▲ 248.4% | 81 ▼ 81.0% | -166 ▼ 306.1% | |
| Less: Non-controlling Interests | — | — | — | -2 | -2 ▼ 10.8% | -4 ▼ 119.0% | -1 ▲ 75.1% | |
| Net Profit (Owner's PAT)Derived | -153 | 0 ▲ 100.0% | 554 ▲ 7912232.9% | -285 ▼ 151.4% | 426 ▲ 249.8% | 84 ▼ 80.2% | -165 ▼ 295.9% | |
| PAT Growth YoY %Derived | — | 100.00% | 79,12,232.86% | -151.38% | 249.76% | -80.19% | -295.91% | |
| Earnings Per Share (EPS ₹) | -1.11 | — ▲ 100.0% | 4.01 | -2.06 ▼ 151.4% | 3.08 ▲ 249.5% | 0.61 ▼ 80.2% | -1.20 ▼ 296.7% | |
| Diluted Shares Outstanding (Cr) | 138 | 138 ▲ 0.0% | 138 ▲ 0.0% | 138 ▲ 0.0% | 138 ▲ 0.0% | 138 ▲ 0.0% | 138 ▲ 0.0% | |
| Share of Profit from Associates/JVs | -153 | — ▲ 100.0% | — | -13 | — ▲ 100.0% | — | — | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▼ 4772.7% | -0 ▼ 172.0% | 0 ▲ 294.1% | 0 ▲ 62.2% | 1 ▲ 37.9% | 3 ▲ 341.2% | |
| Fees & Commission Expense | — | — | — | — | — | 920 | 1,309 ▲ 42.3% | |
| Impairment On Financial Instruments | — | — | — | — | — | 1 | 0 ▼ 88.9% | |
| Net Gain Fair Value Changes | — | — | — | — | — | 166 | 2 ▼ 99.0% | |
| Net Loss Fair Value Changes | — | — | — | — | — | — | 172 | |
| Revenue Sale Of Product | — | — | — | — | — | 6,687 | 7,517 ▲ 12.4% | |
| Rental Income | — | — | — | — | — | 0 | — ▼ 100.0% |
RATTANINDIA ENT segment analysis : revenue and profit mix.
Disclosed business segments at RATTANINDIA ENT with their share of revenue and profit, switchable between consolidated and standalone reporting.
RATTANINDIA ENT discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for RATTANINDIA ENT.
Our AI distills the core fundamental drivers supporting RATTANINDIA ENT, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
RATTANINDIA ENT's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.38. Balance sheet risk re-prices growth multiples fast.
RATTANINDIA ENT peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — RATTANINDIA ENT is highlighted for quick read-across.
Quick Compare
RATTANINDIA ENT chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for RATTANINDIA ENT — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
RATTANINDIA ENT delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for RATTANINDIA ENT over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in RATTANINDIA ENT stood at 51.9% of traded volume, against a 20-day average of 49.7%.
RATTANINDIA ENT announcements: results, concalls, ratings, M&A.
Filings RATTANINDIA ENT sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
RATTANINDIA ENT files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 101 documents below.
Copy of Newspaper Publication
RattanIndia Enterprises Limited has informed the Exchange about Copy of Newspaper Clipping: Notice of 16th Annual General Meeting, E-voting and Book…
Shareholders meeting
RattanIndia Enterprises Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026 and Annual…
Outcome of Board Meeting
RattanIndia Enterprises Limited has informed the Exchange regarding 16th Annual General Meeting of RattanIndia Enterprises Limited ('Company'),…
General Updates
RattanIndia Enterprises Limited has informed the Exchange about Investors Presentation for the Quarter ended June 30, 2026.
Outcome of Board Meeting
RattanIndia Enterprises Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
Investor decks & rating reports.
General Updates
General Updates
General Updates
General Updates
General Updates
General Updates
RATTANINDIA ENT dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue RATTANINDIA ENT has declared, sequenced by announce and record date.
RATTANINDIA ENT corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About RATTANINDIA ENT: business, sector, key facts.
What RATTANINDIA ENT does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
RATTANINDIA ENT operates in the E-Retail/ E-Commerce industry under the Consumer Services sector, listed as NSE: RTNINDIA, BSE: 534597.
RattanIndia Enterprises Limited (RIEL) is a diversified Indian conglomerate offering a wide array of services and products across several sectors. Its core business operations are segmented into Retail-E-commerce, Electric Vehicles (EV), and Others, showcasing its strategic diversification approach.
RIEL's retail e-commerce segment focuses on the online sale of diverse consumer goods. This includes apparel (fashion, denim, athleisure, casual, and performance wear under brands like Fyltr, Pump'd, and Inkd), eyewear, shoes, handbags, office supplies, electronics accessories, musical instruments, and books. The company leverages various e-commerce platforms to reach a broad customer base.
The EV segment represents a significant area of growth for RIEL. It involves manufacturing electric motor vehicles and acting as a dealer for Revolt products, providing associated after-sales services. This segment highlights RIEL's commitment to emerging technologies and sustainable transportation solutions within the Indian market.
The "Others" segment encompasses a vast range of activities, including financial services (personal loans, two-wheeler loans, credit cards, and business loans), fintech operations, insurance broking, management and project consultancy, and monetary intermediation. Furthermore, RIEL utilizes drone technology across sectors like agriculture, delivery and logistics, energy, media and entertainment, real estate, construction, and security and law enforcement, showcasing its technological expertise and adaptability.
In addition to these core segments, RIEL engages in re-branding activities for retail goods and provides manpower, human resource supply, and consultancy services, along with payroll management. This diverse portfolio positions RIEL as a multi-faceted business entity operating within a complex and evolving Indian market.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- CARTRADE TECH (CARTRADE) Share PricePeer
- ETERNAL - ZOMATO (ETERNAL) Share PricePeer
- BRAINBEES SOLUTIONS (FIRSTCRY) Share PricePeer
- INTRASOFT TECH (ISFT) Share PricePeer
- FSN E COMMERCE VENTURES (NYKAA) Share PricePeer
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about RATTANINDIA ENT (RTNINDIA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of RATTANINDIA ENT (RTNINDIA)?
The current share price of RATTANINDIA ENT (RTNINDIA) is ₹27.68. Today, the stock has gained by ₹0.08 (0.29%), trading in a range of ₹27.00 to ₹28.00. The stock opened at ₹27.48 with a trading volume of 17,56,505 shares.
02Is RATTANINDIA ENT stock a good investment for long-term?
RATTANINDIA ENT can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,834.42 Cr., P/E ratio of 0, ROE of -20.75%, and ROCE of -10.13%. The dividend yield stands at 0%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of RATTANINDIA ENT stock?
The 52-week high price of RATTANINDIA ENT (RTNINDIA) is ₹59.42, while the 52-week low is ₹24.40. Currently trading at ₹27.68, the stock is 13.44% above its 52-week low and 53.42% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy RATTANINDIA ENT stock at the current price?
Whether to buy RATTANINDIA ENT stock at ₹27.68 depends on multiple factors. The stock is currently trading with a P/E ratio of 0 and P/B ratio of 4.99. Today's performance shows a gain of 0.29%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of RATTANINDIA ENT and when is the next dividend?
RATTANINDIA ENT offers a dividend yield of 0%, which means for every ₹100 invested at the current price of ₹27.68, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of RATTANINDIA ENT?
RATTANINDIA ENT's key financial metrics include: P/E Ratio: 0, P/B Ratio: 4.99, ROE: -20.75%, ROCE: -10.13%, Dividend Yield: 0%, EPS: ₹-0.06, Book Value: ₹5.57, and Debt-to-Equity: 0.88. The company's market cap stands at ₹3,834.42 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is RATTANINDIA ENT stock performing today in the market?
RATTANINDIA ENT stock opened at ₹27.48 and is currently trading at ₹27.68, showing a gain of ₹0.08 (0.29%). The intraday high is ₹28.00 and low is ₹27.00. The trading volume stands at 17,56,505 shares, indicating strong market participation today.
08What is the P/E ratio of RATTANINDIA ENT and what does it indicate?
RATTANINDIA ENT has a Price-to-Earnings (P/E) ratio of 0, which means investors are willing to pay 0.00 for every ₹1 of earnings. With an EPS of ₹-0.06, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about RATTANINDIA ENT (RTNINDIA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.